Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s stock price traded up 14.5% during trading on Thursday . The company traded as high as $135.83 and last traded at $135.83. 7 shares were traded during mid-day trading, a decline of 99% from the average session volume of 877 shares. The stock had previously closed at $118.63.
Pro Medicus Price Performance
The stock’s 50 day simple moving average is $144.48 and its 200-day simple moving average is $176.10.
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Read More
- Five stocks we like better than Pro Medicus
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- What a Former CIA Agent Knows About the Coming Collapse
- Buy This Stock at 9:30 AM on MONDAY!
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
